Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
International Journal of Clinical and Experimental Pathology
|
December 1, 2015
Programmed cell death 2 functions as a tumor suppressor in osteosarcoma
Yuanxun Yang, Yan Jin, Wenxi Du
Clinical Pharmacology in Drug Development
|
July 20, 2023
Pharmacokinetic and Bioequivalence Evaluation of Single-Tablet and Separate-Tablet Regimens for Ainuovirine, Lamivudine, and Tenofovir Disoproxil Fumarate in Chinese Healthy Subjects
Lei Huang, Jing Lei, Yuanxun Yang, et al.
Molecular Biomedicine
|
May 7, 2026
The m<sup>6</sup>A reader IGF2BP2 promotes hepatocellular carcinoma progression via enhancing RELB stability
Hehua Ma, Yuxin Hong, Zhi Xu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
January 11, 2025
Drug interaction evaluation of the novel phosphodiesterase type 5 inhibitor tunodafil (youkenafil): Effects of tunodafil on omeprazole pharmacokinetics based on CYP2C19 gene polymorphism, and effects of ritonavir on tunodafil pharmacokinetics
Keli Wang, Juefang Ding, Minlu Cheng, et al.
Frontiers in Endocrinology
|
February 12, 2025
Effect of SY009, a novel SGLT1 inhibitor, on the plasma metabolome and bile acids in patients with type 2 diabetes mellitus
Haoyi Yang, Yuwen Zhang, Yuxin Hong, et al.
Diabetes, Obesity & Metabolism
|
June 5, 2025
Safety, pharmacokinetics and pharmacodynamics of Efsubaglutide Alfa in healthy participants: A randomised, dose-escalation phase 1 study
Qinghua Wang, Qiaoli Cui, Yulong Xu, et al.
Cell Death Discovery
|
January 15, 2022
ALKBH5-mediated N<sup>6</sup>-methyladenosine modification of TRERNA1 promotes DLBCL proliferation via p21 downregulation
Wei Song, Fei Fei, Fengchang Qiao, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 19, 2023
A randomized double-blind phase Ib clinical trial of SY-009 in patients with type 2 diabetes mellitus
Lei Huang, Bei Cao, Yan Geng, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
October 9, 2023
Phase 1 study to evaluate the effects of rifampin or itraconazole on the pharmacokinetics of limertinib (ASK120067), a novel mutant-selective inhibitor of the epidermal growth factor receptor in healthy Chinese subjects
Bei Cao, Lei Huang, Ming Liu, et al.
Investigational New Drugs
|
April 11, 2024
The effect of food on the pharmacokinetics of Sutetinib maleate capsule, an irreversible EGFR tyrosine kinase inhibitor, in healthy Chinese subjects
Bei Cao, Tingting Ma, Yuqiang Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
International Journal of Clinical and Experimental Pathology
|
December 1, 2015
Programmed cell death 2 functions as a tumor suppressor in osteosarcoma
Yuanxun Yang, Yan Jin, Wenxi Du
Clinical Pharmacology in Drug Development
|
July 20, 2023
Pharmacokinetic and Bioequivalence Evaluation of Single-Tablet and Separate-Tablet Regimens for Ainuovirine, Lamivudine, and Tenofovir Disoproxil Fumarate in Chinese Healthy Subjects
Lei Huang, Jing Lei, Yuanxun Yang, et al.
Molecular Biomedicine
|
May 7, 2026
The m<sup>6</sup>A reader IGF2BP2 promotes hepatocellular carcinoma progression via enhancing RELB stability
Hehua Ma, Yuxin Hong, Zhi Xu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
January 11, 2025
Drug interaction evaluation of the novel phosphodiesterase type 5 inhibitor tunodafil (youkenafil): Effects of tunodafil on omeprazole pharmacokinetics based on CYP2C19 gene polymorphism, and effects of ritonavir on tunodafil pharmacokinetics
Keli Wang, Juefang Ding, Minlu Cheng, et al.
Frontiers in Endocrinology
|
February 12, 2025
Effect of SY009, a novel SGLT1 inhibitor, on the plasma metabolome and bile acids in patients with type 2 diabetes mellitus
Haoyi Yang, Yuwen Zhang, Yuxin Hong, et al.
Diabetes, Obesity & Metabolism
|
June 5, 2025
Safety, pharmacokinetics and pharmacodynamics of Efsubaglutide Alfa in healthy participants: A randomised, dose-escalation phase 1 study
Qinghua Wang, Qiaoli Cui, Yulong Xu, et al.
Cell Death Discovery
|
January 15, 2022
ALKBH5-mediated N<sup>6</sup>-methyladenosine modification of TRERNA1 promotes DLBCL proliferation via p21 downregulation
Wei Song, Fei Fei, Fengchang Qiao, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 19, 2023
A randomized double-blind phase Ib clinical trial of SY-009 in patients with type 2 diabetes mellitus
Lei Huang, Bei Cao, Yan Geng, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
October 9, 2023
Phase 1 study to evaluate the effects of rifampin or itraconazole on the pharmacokinetics of limertinib (ASK120067), a novel mutant-selective inhibitor of the epidermal growth factor receptor in healthy Chinese subjects
Bei Cao, Lei Huang, Ming Liu, et al.
Investigational New Drugs
|
April 11, 2024
The effect of food on the pharmacokinetics of Sutetinib maleate capsule, an irreversible EGFR tyrosine kinase inhibitor, in healthy Chinese subjects
Bei Cao, Tingting Ma, Yuqiang Zhang, et al.
Page
of 2